IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q1 2020 Holdings

Filed 2020-05-14 | 11 holdings | $25.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-05-28) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Incorporated(CYTK)COM23282W605$25.7M2,177,29299.8%
Myokardia, Inc.COM62857M105$14.4K307,4000.1%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$11.9K998,6550.0%
Insmed Incorporated(INSM)COM457669307$10.9K678,3220.0%
Biohaven Pharmaceutical Holding Company Ltd.(BHVN)COMG11196105$5.3K156,3550.0%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$4.7K516,7510.0%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$3.1K227,7170.0%
bluebird bio, Inc.ACOM09609G100$2.3K50,0000.0%
Blueprint Medicines Corporation(2L9)COM09627Y109$2.3K50,0000.0%
Kiniksa Pharmaceuticals, Ltd.COMG5269C101$1.0K65,0000.0%
Kura Oncology, Inc.(KURA)COM50127T109$92593,0000.0%
uniQure N.V.(QURE)SHSN90064101$90519,0820.0%